These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27311182)

  • 41. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
    Greenwald MW; Shergy WJ; Kaine JL; Sweetser MT; Gilder K; Linnik MD
    Arthritis Rheum; 2011 Mar; 63(3):622-32. PubMed ID: 21360491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comments on the paper showing an exceptionally favorable response to tofacitinib among Japanese rheumatoid patients and an issue surrounding clinical trial led by pharmaceutical company.
    Minota S
    Mod Rheumatol; 2015 May; 25(3):493-4. PubMed ID: 24884482
    [No Abstract]   [Full Text] [Related]  

  • 43. Perspectives on rheumatoid arthritis for the orthopedic surgeon: overview of non-tumor necrosis factor biologic drugs and perioperative management.
    Keith MP
    Am J Orthop (Belle Mead NJ); 2011 Dec; 40(12):E272-5. PubMed ID: 22268021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis].
    Chinese Rheumatology Association
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):242-251. PubMed ID: 29614581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.
    Tsao NW; Shojania K; Marra CA
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):9-18. PubMed ID: 24325566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].
    Kameda H; Takeuchi T
    Nihon Rinsho; 2013 Jul; 71(7):1166-71. PubMed ID: 23961662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.
    Guyot P; Taylor PC; Christensen R; Pericleous L; Drost P; Eijgelshoven I; Bergman G; Lebmeier M
    J Rheumatol; 2012 Jun; 39(6):1198-206. PubMed ID: 22505698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials.
    Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S19-21. PubMed ID: 24129131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment.
    Cohen S; Zwillich SH; Chow V; Labadie RR; Wilkinson B
    Br J Clin Pharmacol; 2010 Feb; 69(2):143-51. PubMed ID: 20233177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [How early would we really administer biologics?].
    Nüßlein HG
    Z Rheumatol; 2012 Dec; 71(10):838-9. PubMed ID: 23202994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Methotrexate for therapy of rheumatoid arthritis].
    Suzuki Y; Wakabayashi T; Jackson K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():498-502. PubMed ID: 15799406
    [No Abstract]   [Full Text] [Related]  

  • 53. Serious adverse events-missing in action: comment on the article by Kremer et al.
    Leonardi CL
    Arthritis Rheum; 2012 Sep; 64(9):3055-6; author reply 3056-7. PubMed ID: 22674338
    [No Abstract]   [Full Text] [Related]  

  • 54. When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.
    Fraenkel L; Miller AS; Clayton K; Crow-Hercher R; Hazel S; Johnson B; Rott L; White W; Wiedmeyer C; Montori VM; Singh JA; Nowell WB
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):26-35. PubMed ID: 26545701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.
    Fleischmann R
    Expert Opin Biol Ther; 2010 May; 10(5):773-86. PubMed ID: 20230188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New therapies for rheumatoid arthritis].
    Salgado E; Maneiro JR
    Med Clin (Barc); 2014 Nov; 143(10):461-6. PubMed ID: 24461738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discussion. Treatment algorithm: managing rheumatoid arthritis.
    Calabrese DC; Konop R; Cannon E; Maves TK; Casberg JJ; Meske L; Coleman IC; Orland BI; Florentine MJ; Southwell Y; Harris MR; Yoder DM
    Manag Care; 2001 Jul; 10(7 Suppl):19-24. PubMed ID: 11729430
    [No Abstract]   [Full Text] [Related]  

  • 58. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
    Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
    Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
    Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy.
    Chen YM; Huang WN; Liao TL; Chen JP; Yang SS; Chen HH; Hsieh TY; Hung WT; Chen YH; Chen DY
    Ann Rheum Dis; 2019 Jun; 78(6):849-850. PubMed ID: 30606739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.